KCM
PBYI icon

Kynam Capital Management’s Puma Biotechnology PBYI Stock Holding History

Kynam Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-473,975
Closed -$1.25M – 33
2023
Q3 		$1.25M Buy
473,975
+905
+0.2% +$3.08K 0.21% 25
2023
Q2 		$1.67M Hold
473,070
– – 0.26% 20
2023
Q1 		$1.46M Sell
473,070
-88,539
-16% -$334K 0.19% 29
2022
Q4 		$2.38M Buy
561,609
+1,840
+0.3% +$6.35K 0.36% 25
2022
Q3 		$1.33M Sell
559,769
-20,146
-3% -$58.8K 0.28% 28
2022
Q2 		$1.65M Sell
579,915
-73,530
-11% -$183K 0.43% 26
2022
Q1 		$1.88M Sell
653,445
-30,174
-4% -$78K 0.61% 22
2021
Q4 		$2.08M Buy
+683,619
New +$2.97M 1.11% 24

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return